Dexcom, Inc. revenue by year
Over the 10 fiscal years shown, revenue went from $573.30M (year ended Dec 31, 2016) to $4.66B (year ended Dec 31, 2025), a compound annual growth rate of 26.2%. The fastest growth was +43.6% in the year ended Dec 31, 2018; the weakest year was +11.3% (year ended Dec 31, 2024).
Annual revenue
| Fiscal year ended | Revenue (USD) | Change | XBRL concept | Reported in |
|---|---|---|---|---|
| Dec 31, 2025 | $4.66B | +15.6% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 12, 2026 |
| Dec 31, 2024 | $4.03B | +11.3% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 12, 2026 |
| Dec 31, 2023 | $3.62B | +24.5% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 12, 2026 |
| Dec 31, 2022 | $2.91B | +18.8% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 18, 2025 |
| Dec 31, 2021 | $2.45B | +27.1% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 8, 2024 |
| Dec 31, 2020 | $1.93B | +30.5% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 9, 2023 |
| Dec 31, 2019 | $1.48B | +43.1% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 14, 2022 |
| Dec 31, 2018 | $1.03B | +43.6% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 11, 2021 |
| Dec 31, 2017 | $718.50M | +25.3% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 13, 2020 |
| Dec 31, 2016 | $573.30M | +42.6% | RevenueFromContractWithCustomerExcludingAssessedTax | 10-K filed Feb 21, 2019 |
Quarterly revenue
Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.
| Quarter | Revenue (USD) | vs same quarter a year earlier | Source |
|---|---|---|---|
| 3 months ended Sep 30, 2026 | $1.34B | +11.2% | 10-Q filed Oct 29, 2026 |
| 3 months ended Jun 30, 2026 | $1.31B | +13.1% | 10-Q filed Jul 30, 2026 |
| 3 months ended Mar 31, 2026 | $1.19B | +15.0% | 10-Q filed Apr 30, 2026 |
| 3 months ended Sep 30, 2025 | $1.21B | +21.6% | 10-Q filed Oct 29, 2026 |
| 3 months ended Jun 30, 2025 | $1.16B | +15.2% | 10-Q filed Jul 30, 2026 |
| 3 months ended Mar 31, 2025 | $1.04B | +12.5% | 10-Q filed Apr 30, 2026 |
| 3 months ended Sep 30, 2024 | $994.20M | +2.0% | 10-Q filed Oct 30, 2025 |
| 3 months ended Jun 30, 2024 | $1.00B | +15.3% | 10-Q filed Jul 30, 2025 |
Source: SEC EDGAR XBRL company facts for CIK 1093557 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.